In trading on Wednesday, the First Trust NYSE Arca Biotechnology Index Fund ETF is leading the pack, showing an impressive increase of approximately 3.7% for the day. Notably, several components within this ETF are driving this performance. Among them, shares of Moderna have surged by about 8.8%, while Regeneron Pharmaceuticals has also made significant gains, rising by 8.3%. This robust performance highlights the ongoing strength in the biotechnology sector, which continues to attract investor interest.
On the flip side, the **VanEck BDC Income ETF** is struggling, down about **3.9%** in Wednesday afternoon trading. This decline is particularly evident among its components, with **Sixth Street Specialty Lending** experiencing a drop of approximately **2.2%**. Additionally, shares of the **Morgan Stanley Direct Lending Fund** are also underperforming, down by **1.7%** for the day. Such movements reflect the challenges faced by certain sectors in the current market environment, contrasting sharply with the gains seen in biotechnology.
VIDEO: Wednesday’s ETF Movers: FBT, BIZD
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
